Medicare Part D coverage · delafloxacin · RxCUI 1927682
delafloxacin 450 MG Oral Tablet [Baxdela]
Per the CMS 2026 Part D formulary file, delafloxacin 450 MG Oral Tablet [Baxdela] is covered by 103 Medicare Part D plans (2% of enrollable products), averaging Tier 4.1, with prior authorization required on 66.7% of covering formularies.
- 2%
- Plan coverage
- 103
- Plans covering
- T4.1
- Avg tier
- 66.7%
- Prior auth required
What the CMS Formulary Data Shows for delafloxacin 450 MG Oral Tablet [Baxdela]
Per the CMS 2026 Part D formulary file, delafloxacin 450 MG Oral Tablet [Baxdela] (RxNorm concept RXCUI 1927682, generic name delafloxacin) appears on 15 distinct formulary files spanning 103 Medicare Part D plan offerings - 2% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 4.1.
Real-world access to delafloxacin 450 MG Oral Tablet [Baxdela] depends on utilization management as much as tier placement: 66.7% of covering formularies require prior authorization. 0% require step therapy. 53.3% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 343 Part D beneficiaries filled delafloxacin 450 MG Oral Tablet [Baxdela] in 2023, with total plan-and-beneficiary spending of $1,142,194 and an average per-beneficiary annual cost of $3,330.01. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry delafloxacin 450 MG Oral Tablet [Baxdela] today.
Coverage Details
- Formularies covering
- 15
- Plans covering
- 103
- Coverage rate
- 2%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 66.7% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 53.3% of formularies
2023 Medicare Spending
- Beneficiaries
- 343
- Total spending
- $1,142,194
- Avg per beneficiary
- $3,330.01
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering delafloxacin 450 MG Oral Tablet [Baxdela]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T2 | Yes | $0 | CA |
| Freedom VIP Care (HMO C-SNP) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom VIP Savings (HMO C-SNP) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom VIP Savings (HMO C-SNP) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom VIP Rewards (HMO C-SNP) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom VIP Rewards (HMO C-SNP) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Optimum Diamond Rewards (HMO C-SNP) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Optimum Diamond Savings (HMO C-SNP) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Optimum Diamond Rewards (HMO C-SNP) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Optimum Diamond (HMO C-SNP) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Freedom Medi-Medi Partial (HMO D-SNP) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom Medi-Medi Full (HMO D-SNP) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Optimum Emerald Partial (HMO D-SNP) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Optimum Emerald Full (HMO D-SNP) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Freedom Medicare Plan Rx (HMO) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom Medicare Plan Rx (HMO) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom VIP Savings COPD (HMO C-SNP) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom VIP Savings COPD (HMO C-SNP) | Freedom Health, Inc. | T4 | No | $0 | FL |
Show the next 30 plans
| Freedom Platinum Plan Rx (HMO) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom Platinum Plan Rx (HMO) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom Platinum Plan Rx (HMO) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom Platinum Plan Rx (HMO) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom Platinum Plan Rx (HMO) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom Platinum Rewards Plan Rx (HMO) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom Platinum Rewards Plan Rx (HMO) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom Platinum Rewards Plan Rx (HMO) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom Platinum Rewards Plan Rx (HMO) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom Platinum Rewards Plan Rx (HMO) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom Platinum Rewards Plan Rx (HMO) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom Máximo (HMO-POS) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom Máximo (HMO-POS) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Optimum Gold Rewards Plan (HMO) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Optimum Platinum Plan (HMO) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Optimum Gold Plan (HMO) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Optimum Gold Rewards Plan (HMO) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Optimum Gold Rewards Plan (HMO) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Optimum Diamond Rewards COPD (HMO C-SNP) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Optimum Diamond Savings COPD (HMO C-SNP) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Optimum Gold Plus Plan (HMO) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Optimum Diamond Rewards COPD (HMO C-SNP) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | No | $0 | UT |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | No | $0 | NV |
| Select Health Medicare Dual (HMO D-SNP) | Selecthealth, Inc. | T5 | No | $0 | UT |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | No | $0 | UT |
| Select Health Medicare + Kroger (HMO) | Selecthealth, Inc. | T5 | No | $0 | NV |
| Select Health Medicare + Kroger (HMO) | Selecthealth, Inc. | T5 | No | $0 | UT |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | No | $0 | CO |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | No | $0 | CO |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is delafloxacin 450 MG Oral Tablet [Baxdela] covered by Medicare Part D?
Yes, delafloxacin 450 MG Oral Tablet [Baxdela] is covered by 103 Medicare Part D plans (2% of all Part D formularies).
What tier is delafloxacin 450 MG Oral Tablet [Baxdela] on Medicare Part D plans?
delafloxacin 450 MG Oral Tablet [Baxdela] averages Tier 4.1 across Part D plans, ranging from Tier 1 to Tier 6.
Does delafloxacin 450 MG Oral Tablet [Baxdela] require prior authorization?
66.7% of Part D formularies require prior authorization for delafloxacin 450 MG Oral Tablet [Baxdela]. Step therapy: 0%. Quantity limits: 53.3%.
How much does Medicare spend on delafloxacin 450 MG Oral Tablet [Baxdela]?
In 2023, total Medicare Part D spending on delafloxacin 450 MG Oral Tablet [Baxdela] was $1,142,194, covering 343 beneficiaries. The average spend per beneficiary was $3,330.01.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- {14 (cenobamate 100 MG Oral Tablet [Xcopri]) / 14 (cenobamate 50 MG Oral Tablet [Xcopri]) } Pack [Xcopri Titration Pack - 50 MG (14), 100 MG (14) 28 Count] T4.1
- {28 (cenobamate 150 MG Oral Tablet [Xcopri]) / 28 (cenobamate 200 MG Oral Tablet) } Pack [Xcopri 350 MG Maintenance Pack] T4.1
- atazanavir 50 MG Oral Powder [Reyataz] T4.1
- cenobamate 50 MG Oral Tablet [Xcopri] T4.1
- clobazam 10 MG Oral Film [Sympazan] T4.1
- pimavanserin 10 MG Oral Tablet [Nuplazid] T4.1
Similar prior-authorization rate
- meperidine hydrochloride 10 MG/ML Oral Solution 66.7% PA
- tretinoin 0.25 MG/ML Topical Cream [Retin-A] 66.7% PA
- 1 ML meperidine hydrochloride 25 MG/ML Injection 66.7% PA
- tazarotene 0.5 MG/ML Topical Cream [Tazorac] 66.7% PA
- Modified 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet 66.7% PA
- 0.2 ML adalimumab-atto 100 MG/ML Prefilled Syringe [Amjevita] 66.7% PA